|Articles|February 1, 2019 (Updated: November 15, 2020)
- Pharmaceutical Executive-02-01-2019
- Volume 39
- Issue 2
Pharmaceutical Executive, February 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Q&A: Regulatory Reform in Chinaabout 7 years ago
China: A Change in Attitudeabout 7 years ago
New Roads to Chinaabout 7 years ago
Closing the Pharma and Digital Health Divideabout 7 years ago
A Leading Man’s Next Actabout 7 years ago
Two Steps Forwardabout 7 years ago
Let the Drug Pricing Games Beginabout 7 years ago
Mixed Outlook for China Life Sciencesabout 7 years ago
CFIUS Reform’s Impact on Biopharmaabout 7 years ago
Op-Ed: Opening the Golden DoorNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5